Woodford biotech holding admits 'material weakness' in finance controls

Shares dropped 90% since summer

Daniel Flynn
clock • 1 min read

Northwest Biotherapeutics, the US-listed biotech company in which Neil Woodford holds a 25% stake, has admitted its plans to improve financial controls are "uncertain" amid reports it is incapable of policing internal fraud.

Its latest annual report, the group, which has seen shares plunge 90% since last Summer, revealed seven "material weaknesses" in its financial controls and said its plans to improve these were "uncertain," according to The Sunday Times. It reportedly admitted a "lack of controls to ensure that all material transactions and developments are properly recorded". Woodford's funds hit by September biotech sell-off This follows allegations the company's chief executive, Linda Powers, has transferred millions of dollars from Northwest into other businesses she controls. The company, wh...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on US

US adds just 12,000 jobs as unemployment rate remains unchanged
US

US adds just 12,000 jobs as unemployment rate remains unchanged

Significantly below expectations

Sorin-Andrei Dojan
clock 01 November 2024 • 2 min read
Portfolio managers take defensive stance to mitigate risk of 'coin toss' US election
US

Portfolio managers take defensive stance to mitigate risk of 'coin toss' US election

Hedging their bets

Linus Uhlig
clock 01 November 2024 • 5 min read
Morningstar's Michael Field: European equities poised for volatility amid US election outcomes
US

Morningstar's Michael Field: European equities poised for volatility amid US election outcomes

'Period of uncertainty'

Michael Field
clock 01 November 2024 • 3 min read
Trustpilot